Tomas Frahm Nielsen
Papers
1
Total Citations
9
H-Index
1
About
Dr. Tomas Frahm Nielsen is a leading figure in the advancement of prostate cancer diagnostics, with a specialized focus on the precision and technological evolution of MRI-targeted biopsy techniques. His work critically addresses the comparative efficacy of manually operated versus robot-assisted in-bore magnetic resonance imaging targeted biopsy (MRGB), a pivotal area for improving cancer detection rates while minimizing procedural invasiveness. In his most cited 2022 study, which has garnered 9 citations, Dr. Nielsen directly compared these two approaches, providing essential evidence on their diagnostic yields and operational advantages. This research has significant implications for clinical decision-making, helping to define best practices for integrating robotic assistance into prostate cancer diagnosis. By systematically evaluating these cutting-edge biopsy methods, Dr. Nielsen contributes to the broader goal of enhancing diagnostic accuracy and patient outcomes in urologic oncology, marking him as a key contributor to the refinement of image-guided interventions.
Research Focus
Key Achievements
Top Papers
- 1